YAP1 activation is associated with the progression and response to immunotherapy of non-muscle invasive bladder cancer

BACKGROUND: Despite the availability of several treatments for non-muscle-invasive bladder cancer (NMIBC), many patients are still not responsive to treatments, and the disease progresses. A new prognostic classifier can differentiate between treatment response and progression, and it could be used...

Descripción completa

Detalles Bibliográficos
Autores principales: Baek, Seung-Woo, Mun, Jeong-Yeon, Jang, In-Hwan, Yang, Gi-Eun, Jeong, Mi-So, Kim, Seon-Kyu, Nam, Jong-Kil, Chu, In-Sun, Leem, Sun-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166372/
https://www.ncbi.nlm.nih.gov/pubmed/35665684
http://dx.doi.org/10.1016/j.ebiom.2022.104092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166372/
https://www.ncbi.nlm.nih.gov/pubmed/35665684
http://dx.doi.org/10.1016/j.ebiom.2022.104092

Ejemplares similares